Q32 Bio Inc. (LON:0T6G)
3.591
+0.031 (0.88%)
Feb 12, 2026, 3:28 PM GMT
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of 34.59 million as of February 12, 2026. Its market cap has increased by 9.65% in one year.
Market Cap
34.59M
Enterprise Value
11.09M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.59
Market Cap Chart
Since March 26, 2024, Q32 Bio's market cap has decreased from 157.73M to 34.59M, a decrease of -78.07%. That is a compound annual growth rate of -55.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 34.59M | 13.98% |
| Dec 31, 2025 | 30.35M | -9.32% |
| Dec 31, 2024 | 33.47M | -78.78% |
| Mar 26, 2024 | 157.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Kooth | 48.10M |
| AOTI, Inc. | 44.67M |
| hVIVO | 41.16M |
| Ondine Biomedical | 39.98M |